On the public citation graph

Self-Remedied Nanomedicine for Surmounting the Achilles’ Heel of Photodynamic Tumor Therapy

0 signed · 52 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/adhm.201900132openalex-snapshot
Photosensitizers for Photodynamic Therapy
inferredcites →https://doi.org/10.1002/adma.201805888openalex-snapshot
Tumor Microenvironment‐Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
inferredcites →https://doi.org/10.1002/anie.201805138openalex-snapshot
Innovative Strategies for Hypoxic‐Tumor Photodynamic Therapy
inferredcites →https://doi.org/10.1002/anie.201805246openalex-snapshot
Advanced Photosensitizer Activation Strategies for Smarter Photodynamic Therapy Beacons
inferredcites →https://doi.org/10.1002/med.21477openalex-snapshot
Hypoxia‐inducible factor‐1 (HIF‐1) inhibitors from the last decade (2007 to 2016): A “structure–activity relationship” perspective
inferredcites →https://doi.org/10.1002/smll.202004829openalex-snapshot
Carrier‐Free Platinum Nanomedicine for Targeted Cancer Therapy
inferredcites →https://doi.org/10.1007/s12274-016-1059-0openalex-snapshot
Inhibition of hypoxia-inducible factor 1 with acriflavine sensitizes hypoxic tumor cells to photodynamic therapy with zinc phthalocyanine-encapsulating cationic liposomes
inferredcites →https://doi.org/10.1016/j.actbio.2020.09.047openalex-snapshot
Tumor Targeted Self-Synergistic Nanoplatforms for Arsenic-Sensitized Photodynamic Therapy
inferredcites →https://doi.org/10.1016/j.apsb.2015.05.007openalex-snapshot
HIF-1α pathway: role, regulation and intervention for cancer therapy
inferredcites →https://doi.org/10.1016/j.apsb.2020.01.009openalex-snapshot
Delivery strategies for macromolecular drugs in cancer therapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2016.10.016openalex-snapshot
Drug self-delivery systems for cancer therapy
inferredcites →https://doi.org/10.1016/j.biomaterials.2019.119341openalex-snapshot
Liposomal formulations of photosensitizers
inferredcites →https://doi.org/10.1016/j.biomaterials.2020.119827openalex-snapshot
Advances in nanomaterials for photodynamic therapy applications: Status and challenges
inferredcites →https://doi.org/10.1016/j.biomaterials.2020.120557openalex-snapshot
Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy
inferredcites →https://doi.org/10.1016/j.cmet.2006.01.012openalex-snapshot
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
inferredcites →https://doi.org/10.1016/j.jconrel.2019.12.041openalex-snapshot
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
inferredcites →https://doi.org/10.1016/j.jconrel.2020.05.029openalex-snapshot
Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia
inferredcites →https://doi.org/10.1021/acs.accounts.0c00606openalex-snapshot
Heavy-Atom-Free Photosensitizers: From Molecular Design to Applications in the Photodynamic Therapy of Cancer
inferredcites →https://doi.org/10.1021/acs.chemrev.8b00626openalex-snapshot
Reactive Oxygen Species (ROS)-Based Nanomedicine
inferredcites →https://doi.org/10.1021/acs.nanolett.0c00047openalex-snapshot
Self-Delivery Nanomedicine for O2-Economized Photodynamic Tumor Therapy
inferredcites →https://doi.org/10.1021/acs.nanolett.0c05028openalex-snapshot
Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy
inferredcites →https://doi.org/10.1021/acsami.9b18112openalex-snapshot
Oxygen-Self-Supplying and HIF-1α-Inhibiting Core–Shell Nanosystem for Hypoxia-Resistant Photodynamic Therapy
inferredcites →https://doi.org/10.1021/acsami.9b23325openalex-snapshot
Self-Delivered and Self-Monitored Chemo-Photodynamic Nanoparticles with Light-Triggered Synergistic Antitumor Therapies by Downregulation of HIF-1α and Depletion of GSH
inferredcites →https://doi.org/10.1021/acsnano.0c06765openalex-snapshot
Self-Delivery Photo-Immune Stimulators for Photodynamic Sensitized Tumor Immunotherapy
inferredcites →https://doi.org/10.1021/acsnano.8b05639openalex-snapshot
Regulation of Ca2+ Signaling for Drug-Resistant Breast Cancer Therapy with Mesoporous Silica Nanocapsule Encapsulated Doxorubicin/siRNA Cocktail
inferredcites →https://doi.org/10.1021/acsnano.8b08823openalex-snapshot
Targeted Co-delivery of the Iron Chelator Deferoxamine and a HIF1α Inhibitor Impairs Pancreatic Tumor Growth
inferredcites →https://doi.org/10.1021/jacs.5b09974openalex-snapshot
Emerging Frontiers in Drug Delivery
inferredcites →https://doi.org/10.1038/nrc1187openalex-snapshot
Targeting HIF-1 for cancer therapy
inferredcites →https://doi.org/10.1038/nrc704openalex-snapshot
Hypoxia — a key regulatory factor in tumour growth
inferredcites →https://doi.org/10.1038/s41389-017-0011-9openalex-snapshot
The hypoxic tumour microenvironment
inferredcites →https://doi.org/10.1039/c6cs00271dopenalex-snapshot
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
inferredcites →https://doi.org/10.1039/c6cs00616gopenalex-snapshot
Overcoming the Achilles' heel of photodynamic therapy
inferredcites →https://doi.org/10.1039/c9nr10787hopenalex-snapshot
A nano-photosensitizer based on covalent organic framework nanosheets with high loading and therapeutic efficacy
inferredcites →https://doi.org/10.1039/c9tb00541bopenalex-snapshot
Promoting antitumor efficacy by suppressing hypoxia via nano self-assembly of two irinotecan-based dual drug conjugates having a HIF-1α inhibitor
inferredcites →https://doi.org/10.1126/science.aaf4405openalex-snapshot
Hypoxic control of metastasis
inferredcites →https://doi.org/10.1158/1535-7163.mct-06-0421openalex-snapshot
Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1α
inferredcites →https://doi.org/10.1186/1476-4598-13-7openalex-snapshot
YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma
inferredcites →https://doi.org/10.3322/caac.20114openalex-snapshot
Photodynamic therapy of cancer: An update
inferredcites →https://doi.org/10.3390/biomedicines9010085openalex-snapshot
Current Limitations and Recent Progress in Nanomedicine for Clinically Available Photodynamic Therapy

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.5228138openalex-extracted
An Aie Cyanine Photosensitizer Achieving Hypoxic Tumor Ablation Through Synergistic Treatment of Type I Photodynamic and Photothermal Therapy
inferred← citeshttps://doi.org/10.1002/adhm.202202307openalex-snapshot
Recent Progress in Carrier‐Free Nanomedicine for Tumor Phototherapy
inferred← citeshttps://doi.org/10.1016/j.actbio.2022.08.045openalex-snapshot
Carrier free nanomedicine to reverse anti-apoptosis and elevate endoplasmic reticulum stress for enhanced photodynamic therapy
inferred← citeshttps://doi.org/10.1016/j.canlet.2022.01.012openalex-snapshot
Engineering nanomedicines to inhibit hypoxia-inducible Factor-1 for cancer therapy
inferred← citeshttps://doi.org/10.1016/j.cclet.2022.107827openalex-snapshot
Carrier-free supramolecular nanomedicines assembled by small-molecule therapeutics for cancer treatment
inferred← citeshttps://doi.org/10.1016/j.cclet.2023.109254openalex-snapshot
Feedback enhanced tumor targeting delivery of albumin-based nanomedicine to amplify photodynamic therapy by regulating AMPK signaling and inhibiting GSTs
inferred← citeshttps://doi.org/10.1016/j.cej.2022.139887openalex-snapshot
Self-delivery photothermal converter for feedback enhanced tumor therapy by cascade inflammation inhibition
inferred← citeshttps://doi.org/10.1016/j.colsurfa.2025.138429openalex-snapshot
An AIE cyanine photosensitizer achieving hypoxic tumor ablation through synergistic treatment of type i photodynamic and photothermal therapy
inferred← citeshttps://doi.org/10.1016/j.phrs.2026.109657openalex-snapshot
Nanomedicine design strategy for preferential elimination of cancer stem cells by targeted HIF-Warburg-immune evasion axis: Systematic review
inferred← citeshttps://doi.org/10.1021/acsami.5c13893openalex-snapshot
MOF-Based Nanoplatform Enables Synergistic Hypoxia-Activated Chemotherapy and Chemodynamic Therapy for Colon Cancer
inferred← citeshttps://doi.org/10.1021/acsnano.2c11964openalex-snapshot
Paraptosis Inducer to Effectively Trigger Immunogenic Cell Death for Metastatic Tumor Immunotherapy with IDO Inhibition
inferred← citeshttps://doi.org/10.1021/acsnano.4c09027openalex-snapshot
Carrier-Free Nanodrugs: From Bench to Bedside
inferred← citeshttps://doi.org/10.2139/ssrn.5360683openalex-snapshot
An Aie Cyanine Photosensitizer Achieving Hypoxic Tumor Ablation Through Synergistic Treatment of Type I Photodynamic and Photothermal Therapy
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.